Dr. Hari Deshpande, Associate Professor of Medicine in the Section of Medical Oncology, cares for patients with sarcomas along with the sarcoma multidisciplinary team.
Previously in practice at both the New London Cancer Center and Las Vegas Cancer Center, Dr. Deshpande also has clinical interests in sarcomas, cancers of unknown primary, and thyroid cancers. He is a member of the Head and Neck Cancer and GU cancer teams. He is the Director of the Medical Oncology Inpatient Consult service.
|David S Fischer Annual Teaching Award||Yale Cancer Center||2022|
|David S Fischer Annual Teaching Award||Yale Cancer Center||2018|
|Compassionate Caregiver Award||Smilow Cancer Hospital||2015|
|David S Fischer Annual Teaching Award||Yale Cancer Center||2011|
|Exelixis Advisory Board, Exelixis||Advisor||2021 - Present|
|The Desmoid Tumor Research Foundation, Desmoid Tumor Research Foundation||Advisor||2020 - Present|
|Blueprint Medicines Medical Strategic Council, Blueprint Medicine||Advisor||2020 - Present|
|Daiichi Sankyo Advisory Board, Daiichi Sankyo||Advisor||2019 - Present|
|Deciphera Advisory Board, Deciphera||Advisor||2019 - Present|
|Eisai Advisory Board, Eisai||Advisor||2018 - Present|
|Bristol-Myers Squibb Advisory Board, Bristol-Myers Squibb||Advisor||2018 - Present|
|Annals of Thyroid Research, Austin Publishing Group||Member and Reviewer||2014 - Present|
|FDA||Grant Reviewer, Oncology Panel, FDA Office of Orphan Products Development||2007 - Present|